Table 3. Differences in immune factors in anemic and non-anemic tuberculosis patients.
| Parameter | Non-anemia | Anemia | |||||
|---|---|---|---|---|---|---|---|
| Success | Failure | P value | Success | Failure | P value | ||
| MetHb | 0.7 (0.5–1.1) | 0.9 (0.5–1.2) | 0.699 | 0.9528 | 0.6926 | 0.026 | |
| RDW-SD | 40.9 (39.1–43.3) | 42.1 (40.2–44.3) | 0.252 | 41.85 (39.63–44.03) | 40 (38.2–41.8) | 0.021 | |
| PA | 192.3706 | 194.0769 | 0.896 | 176.5556 | 143.88 | 0.045 | |
| C4 | 0.24 (0.22–0.30) | 0.21 (0.19–0.3) | 0.236 | 0.25 (0.19–0.29) | 0.31 (0.25–0.34) | 0.006 | |
| CRP | 4.4 (3.2–12.5) | 3.2 (3.2–18.75) | 0.825 | 3.2 (3.2–21.5) | 19.5 (6.25–78.35) | 0.016 | |
| A2 | 10.5926 | 7.25 (5.9–10.35) | 0.357 | 9.95 (8.92–11.67) | 11.8269 | 0.023 | |
| TRF | 2.0026 | 1.8196 | 0.039 | 2.0806 | 1.75 | 0.035 | |
| EO% | 1.9 (1–3.3) | 2.7 (1.7–3.8) | 0.031 | 1.55 (0.925–2.7) | 2 (0.9–2.6) | 0.607 | |
| AFU | 16 [14–20] | 19.346 | 0.049 | 14.889 | 15.5 [13–18] | 0.495 | |
| LDL-C | 2.4298 | 2.828 | 0.039 | 2.37 (1.93–2.65) | 2.579 | 0.394 | |
| IgM | 1.13 (0.84–1.56) | 0.9528 | 0.034 | 1.322 | 1.06 (0.825–1.2) | 0.054 | |
| LYM# | 1.69 (1.27–2.02) | 1.591 | 0.33 | 1.564 | 1.15 (0.98–1.79) | 0.219 | |
| MONO | 0.574 | 0.5 (0.41–0.69) | 0.444 | 0.525 (0.4–0.61) | 0.650 | 0.053 | |
| NEUT# | 3.88 (3.12–4.96) | 3.81 | 0.23 | 4.104 | 4.293 | 0.300 | |
P<0.05 is considered statistically significant. MetHb, methemoglobin; RDW-SD, red blood cell distribution width-standard deviation; PA, prealbumin; C4, complement 4; CRP, C-reactive protein; A2, globulin α2; TRF, transferrin; EO%, eosinophil %; AFU, a-L-fucosidase; LDL-C, low-density lipoprotein cholesterol; IgM, immunoglobulin M; LYM#, absolute lymphocyte count; MONO, absolute monocyte count; NEUT#, absolute neutrophil count.